Adverse loss development: $7.3B
U.S. insurers recorded $7.3 billion of adverse loss development in the 'other liability (occurrence)' line for 2025 — a clear sign claims costs are outpacing pricing assumptions. The figure highlights pressure on underwriting reserves and frequency/severity trends in litigious lines. (insurancejournal.com)
S&P’s analysis shows $3.9 billion of one‑year adverse development attributed to accident years 2021–2023 and nearly $3.0 billion of reserve strengthening concentrated in accident years 2022–2023. (carriermanagement.com) S&P’s prior-year work also recorded a $9.98 billion reserve increase for the other‑liability (occurrence) line in 2024, the largest single‑line adverse move since 2008. (spglobal.com) Industry trackers flag social inflation and jury awards as drivers, noting more than 130 “nuclear” verdicts above $10 million in 2024 and a roughly 50% year‑over‑year rise in such verdicts. (taguealliance.com) S&P research lead Tim Zawacki told Carrier Management that pricing “in a broad sense does need to go higher,” singling out personal umbrella and excess coverages while warning competitive dynamics will limit how quickly rates can adjust. (carriermanagement.com) Swiss Re’s US P&C outlook shows carriers added about $16 billion to liability loss estimates in 2024, a move that lifted the calendar‑year loss ratio for liability lines by roughly nine percentage points. (swissre.com) S&P’s authors argue that adverse one‑year Schedule P development concentrated in recent accident years indicates prior ultimates were too low, and market responses cited in commentary include increased use of adverse‑development covers and retrospective reinsurance to manage balance‑sheet strain. (carriermanagement.com) (dlapiper.com)
